PR Newswire PALO ALTO, Calif., Sept. 3, 2024 PALO ALTO, Calif., Sept. 3, 2024 /PRNewswire/ -- Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases, today ...
PR Newswire KANSAS CITY, Mo., Sept. 3, 2024 Septic shock results in approximately 350,000 deaths in the U.S. each year, the leading cause of hospital-related mortality and a major financial burden for the medical system Six trial sites ...
PR Newswire ENCINITAS, Calif. and WROCLAW, Poland, Sept. 3, 2024 ENCINITAS, Calif. and WROCLAW, Poland, Sept. 3, 2024 /PRNewswire/ -- Vasa Therapeutics ("Vasa"), a clinical stage biopharmaceutical company developing novel therapies for ...
PR Newswire SAN FRANCISCO, Sept. 3, 2024 SAN FRANCISCO, Sept. 3, 2024 /PRNewswire/ -- Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic biology driven biopharma company focusing on the ...
PR Newswire CRANBURY, N.J., Aug. 28, 2024 CRANBURY, N.J., Aug. 28, 2024 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the ...
PR Newswire RAICHUR, India, Aug. 28, 2024 RAICHUR, India, Aug. 28, 2024 /PRNewswire/ -- In a major breakthrough, Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) proudly announces the successful completion of its Phase 1 clinical trial ...
PR Newswire SAN ANTONIO, Aug. 27, 2024 Avance Clinical streamlines its biotech clients' clinical trial operations, workflows, and data management, optimizing study efficiencies, minimizing costs, and accelerating trial timelines. SAN ...
PR Newswire MORRISTOWN, N.J., Aug. 26, 2024 AprèsFlex® 5-Day Joint Support Has Been Clinically Demonstrated to Improve Joint Comfort, Flexibility and Function as well as to Provide Ground-Breaking Cartilage Preservation and Protection ...
PR Newswire PHOENIX, Aug. 22, 2024 Trial will Evaluate Effectiveness of Human Amniotic Membrane(s) On Ulcers in Elderly Population PHOENIX, Aug. 22, 2024 /PRNewswire/ -- BioLab Holdings, Inc, a Phoenix-based medical manufacturer ...
PR Newswire CHARLOTTE, N.C., Aug. 19, 2024 CHARLOTTE, N.C., Aug. 19, 2024 /PRNewswire/ -- Falfurrias Management Partners (Falfurrias), a Charlotte-based private equity firm focused on growth-oriented, middle-market businesses, today ...
Vanderbilt’s Phase I trial of VU319 demonstrates promising results for Alzheimer’s and schizophrenia
Late-breaking research finds no survival benefit from autologous stem cell transplant in mantle cell lymphoma patients with undetectable MRD.
Hypovolemic phlebotomy, removing 10% of blood before liver surgery, can cut transfusion needs by 50%, offering a safe, cost-effective way to reduce surgery risks.
Felzartamab, an investigational antibody, reduces triggers linked to IgA nephropathy, an autoimmune kidney disease, suggesting lasting clinical benefits.
Discover how FarrSight ®-Twin technology utilizes digital twins to revolutionize cancer clinical trials by simulating patient responses.
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers